Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/BTT.S87385 http://scihub22266oqcxt.onion/10.2147/BTT.S87385 C5106183!5106183!27853353     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biologics 2016 ; 10 (ä): 149-56 Nephropedia Template TP {{tp|p=27853353|t=2016. Update on sepsis-associated acute kidney injury: emerging targeted therapies |pdf=|usr=}}{{27853353}} gab.com Text Update on sepsis-associated acute kidney injury: emerging targeted therapies JO: Biologics http://www.kidney.de/pget.php?&tw=1&pmid=27853353 #FOAvip Sepsis-associated acute kidney injury (SA-AKI) is an independent predictor of increased mortality and morbidity. It is essential that further advances in the treatment of sepsis should prioritize targeted therapies in SA-AKI in order to improve these bleak outcomes. As yet, a unique therapy that effectively reduces the impact of acute kidney injury has not been demonstrated. However, the emergence of novel targeted therapies, perhaps in combination, has the possibility of significantly reducing the long-term sequelae of an episode of SA-AKI. In this review, we will focus on the shared etiology of these conditions and how this is managed with targeted therapy and finally the emerging novel therapies that may play an additional role to current treatment strategies. Twit Text FOAVip Update on sepsis-associated acute kidney injury: emerging targeted therapies ????Biologics http://www.kidney.de/pget.php?&tw=1&pmid=27853353 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27853353 #FOAvip English Wikipedia <ref>{{Cite pmid|27853353}}</ref> Update on sepsis-associated acute kidney injury: emerging targeted therapies #MMPMID27853353 Doyle JF; Forni LG Biologics 2016[]; 10 (ä): 149-56 PMID27853353show ga Sepsis-associated acute kidney injury (SA-AKI) is an independent predictor of increased mortality and morbidity. It is essential that further advances in the treatment of sepsis should prioritize targeted therapies in SA-AKI in order to improve these bleak outcomes. As yet, a unique therapy that effectively reduces the impact of acute kidney injury has not been demonstrated. However, the emergence of novel targeted therapies, perhaps in combination, has the possibility of significantly reducing the long-term sequelae of an episode of SA-AKI. In this review, we will focus on the shared etiology of these conditions and how this is managed with targeted therapy and finally the emerging novel therapies that may play an additional role to current treatment strategies. äUpdate on sepsis-associated acute kidney injury: emerging targeted the(epmc).pdf DeepDyve Pubget Overpricing